Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,601,194 papers from all fields of science
Search
Sign In
Create Free Account
interferon beta-1b 0.3 MG Injection [Betaseron]
Known as:
INTERFERON BETA-1B 0.3MG/VIL (BETASERON)
, INTERFERON BETA-1B,RECOMBINANT 0.3MG/VIL (BETASERON)
, Betaseron 0.3 MG Injection
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Albumin Human, USP
Betaseron
Drug Allergy
Injection
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
Alemtuzumab - A new efficacy benchmark in relapsing-remitting multiple sclerosis?
O. Khan
2010
Corpus ID: 54978238
The introduction of disease-modifying drugs (DMDs) during the 1990s made chronic therapies that inhibit the disease process in…
Expand
Review
2009
Review
2009
Dose response to interferon therapy in multiple sclerosis: an evaluation of the evidence
S. Freedman
2009
Corpus ID: 73287679
ABSTRACT Background: Interferon beta (IFNβ) is a disease-modifying therapy for multiple sclerosis (MS). Although clinical…
Expand
2007
2007
Clinically Isolated Syndrome: BENEFIT of Early Treatment?
A. Wilner
2007
Corpus ID: 78798401
Early treatment of clinically isolated syndrome (CIS) with subcutaneous interferon beta 1b (IFN-b-1b; Betaseron) may reduce…
Expand
1993
1993
Beyond Betaseron®: current directions for MS research
S. Henahan
1993
Corpus ID: 71600838
The approval of Betaseron® has drawn attention to the potential of immune modulation as a means of treating multiple sclerosis…
Expand